Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physicians' views and practices concerning menopausal hormone therapy.

Haleh Sangi-Haghpeykar1, Alfred N Poindexter

  • 1Baylor College of Medicine, Department of Obstetrics and Gynecology, Houston, TX 77030, United States. halehs@bcm.tmc.edu

Maturitas
|June 27, 2006
PubMed
Summary

Physicians are cautious about prescribing estrogen+progestogen therapy (EPT), especially for prevention. While many accept short-term EPT for menopausal symptoms, they prioritize contraindications like breast cancer history.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of artificial gravity on the vascular system during 60 days of strict head-down tilt bedrest.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations.

Cancer research communications·2026
Same author

Diagnostic Value of Cell-Free DNA Fetal Fraction in Patients With Prenatally Suspected Placenta Accreta Spectrum Disorder.

Prenatal diagnosis·2025
Same author

Association of Community Characteristics as Measured by Social Deprivation Index Score with Prenatal Care and Obstetrical Outcomes.

American journal of perinatology·2024
Same author

A cluster randomized trial of xylitol chewing gum for prevention of preterm birth: The PPaX trial.

Med (New York, N.Y.)·2024
Same author

A survey of contraceptive method use among patients with delayed permanent contraception due to the COVID-19 pandemic.

Contraception·2024

Area of Science:

  • Menopause management
  • Hormone therapy research
  • Physician prescribing practices

Background:

  • Estrogen+progestogen therapy (EPT) is a common treatment for menopausal symptoms.
  • Understanding physician perspectives on EPT is crucial for patient care and safety.
  • Previous studies have highlighted concerns regarding EPT risks and benefits.

Purpose of the Study:

  • To investigate the current views and clinical practices of US physicians regarding estrogen+progestogen therapy (EPT).
  • To identify factors influencing EPT prescription decisions among different medical specialties.

Main Methods:

  • A national survey was conducted in 2003, mailing questionnaires to a random sample of US physicians.
  • Response rate was 53.8%, with 1614 surveys returned from obstetricians/gynecologists (Ob/Gyns), family practitioners, and internists.

Related Experiment Videos

Main Results:

  • Only 16% of physicians would offer EPT without menopausal symptoms, with significant differences across specialties (Ob/Gyn 26%, FP 11%, IM 6%).
  • A majority (62%) believed short-term EPT was acceptable for menopausal symptoms if no contraindications existed (Ob/Gyn 82%, FP 54%, IM 42%).
  • Key contraindications included personal history of breast cancer, thrombosis, and cerebrovascular disease; breast cancer concern was also significant.

Conclusions:

  • Internists and family practitioners considered more contraindications to EPT use compared to Ob-Gyns.
  • Physicians generally supported short-term EPT for menopausal symptoms but largely opposed its prophylactic use.